Opioid dependence with opioid-induced sleep disorder
ICD-10 F11.282 is a billable code used to indicate a diagnosis of opioid dependence with opioid-induced sleep disorder.
Opioid dependence is characterized by a compulsive pattern of opioid use, leading to significant impairment or distress. Patients may develop tolerance, requiring higher doses to achieve the same effect, and may experience withdrawal symptoms when not using opioids. Opioid-induced sleep disorder is a common complication, manifesting as insomnia or hypersomnia, which can exacerbate the dependence cycle. The interplay between opioid use and sleep disturbances is complex; opioids can alter sleep architecture, leading to reduced sleep quality and increased daytime sleepiness. This condition often requires a multidisciplinary approach for effective management, including behavioral therapies, medication-assisted treatment (MAT), and sleep hygiene education. Clinicians must assess both the dependence and the sleep disorder to tailor treatment plans effectively, ensuring that interventions address both aspects of the patient's health.
Comprehensive history of substance use, treatment history, and current medications.
Patients presenting with opioid use disorder and sleep complaints.
Ensure documentation reflects the severity of dependence and associated disorders.
Detailed sleep history, sleep study results, and treatment response.
Patients with sleep apnea or insomnia exacerbated by opioid use.
Document the impact of opioid use on sleep patterns and treatment outcomes.
Used for initial assessment of opioid dependence and sleep disorder.
Detailed assessment notes and treatment plan.
Addiction specialists should document the impact of sleep disorder on treatment.
Coding F11.282 accurately reflects the complexity of managing opioid dependence alongside sleep disorders, ensuring appropriate treatment and reimbursement.
